Women, Black, Asian Patients Least Likely to Get SGLT2 Inhibitors Women, Black, Asian Patients Least Likely to Get SGLT2 Inhibitors
"If left unaddressed, these inequities in [SGLT2 Inhibitor] utilization will continue to widen well-documented disparities in cardiovascular and kidney outcomes in the [United States]."Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Endocrinology | Heart | SGLT2 Inhibitors | Urology & Nephrology | USA Health | Women